Multi Channel Systems MCS GmbH

Reutlingen, Baden-Württemberg, GermanyFounded 199651–100 employeesmultichannelsystems.com

Brain-computer interfaces
EEG and neural monitoring
Neuroscience research tools

Multi Channel Systems develops scientific instruments and software for electrophysiology research, serving university research groups and the pharmaceutical industry. Its portfolio spans microelectrode array systems, stimulus generators, patch clamp and oocyte research tools, and automated screening platforms for biological samples.

Visit multichannelsystems.com ↗

Founded: 1996
Employees: 51–100

reccy insights

Written by reccy's AI from company sites, press and funding records · updated Oct 2026

Recent highlights

The clearest corporate milestone in MCS’s available history is its acquisition by Harvard Bioscience, announced on Oct 1, 2014 for $9.46 million. MCS is listed as an active company and as part of Harvard Bioscience, placing its specialist instrumentation business within a larger life-science tools group. A May 2, 2018 article about Harvard Bioscience’s work on brain and diabetes research devices is also associated with the company, but it does not establish a specific MCS product announcement or partnership. Its current product portfolio spans microelectrode array systems, high-throughput multiwell platforms, CMOS-based recording, and tools for intracellular recordings, reflecting continued coverage of diverse electrophysiology workflows. However, without dated launch information, it is not possible to determine which products are new or to characterize a recent acceleration in releases. Overall, the evidence supports a profile of an established specialist operating within Harvard Bioscience, while providing limited detail on company-specific developments after the acquisition.

Market position

MCS occupies a specialized position in scientific instrumentation, focused on electrophysiology measurement and analysis for university research groups and the pharmaceutical industry. Its category coverage spans biotechnology and test and measurement, distinguishing it from broad laboratory-equipment suppliers through a portfolio centered on electrical recording and stimulation in biological samples. Product descriptions cover neuronal, cardiac, stem-cell, and organoid research, with systems ranging from multiwell screening to high-resolution CMOS arrays. The company also offers complementary approaches, including optical stimulation and a laser-based system for recording intracellular action potentials. These capabilities address workflows across in vitro research and compound screening, rather than a single assay type. MCS became part of Harvard Bioscience through a $9.46 million acquisition announced on Oct 1, 2014, giving it a place within a wider life-science tools business. Its practical differentiation is therefore best described through its breadth of electrophysiology formats, modular systems, and combinations of recording, stimulation, imaging, and automation.

Growth & opportunities

MCS’s trajectory is that of a long-established scientific instrumentation company rather than a newly financed startup. It was founded in 1996 in Reutlingen, Germany, and the major documented corporate inflection point is its acquisition by Harvard Bioscience on Oct 1, 2014 for $9.46 million. The company is currently listed as active and owned by Harvard Bioscience. Its product portfolio indicates breadth across multiple research needs: the MEA2100 family supports recording and stimulation, Multiwell-MEA systems target screening workflows, the CMOS-MEA5000 offers thousands of recording sites, and Mesh MEA is designed for recording activity within organoids. In addition, IntraCell paired with MEA2100 Mini combines laser-based optoporation with array recording. Consequently, the evidence supports continuity and portfolio breadth, but not a confident claim of accelerating growth or a recent change in scale.

Written by reccy's AI from company sites, press and funding records · updated Oct 2026

What makes Multi Channel Systems MCS GmbH distinct

reccy insights

What makes Multi Channel Systems MCS GmbH distinct

01Broad electrophysiology portfolio spanning in vitro and in vivo MEA systems, patch clamp, stimulus generators, and supporting software.
02Scalable recording options, from multiwell screening to high-resolution systems with thousands of recording and stimulation sites.
03Integrated platforms combine electrophysiology with optical imaging, LED-based stimulation, or automated liquid handling.
04Systems support neuronal and cardiac cultures, brain and cardiac slices, retina preparations, and compound screening.
05Some platforms enable recordings inside humidified CO₂ incubators to maintain sample conditions.

Technology & products6

Technology & products

Mesh MEA
A microelectrode array chip with 60 electrodes on a 7µm-thin polyimide mesh for recording electrical activity inside organoids without damaging their structure.
IntraCell & MEA2100 Mini
A laser-based optoporation system combined with a microelectrode array system to capture intracellular action potentials from 2D cardiac monolayers and 3D cardiac organoids.
IFB-C Multiboot Interface Board
An interface board that supports multiple recording systems with programmable DSP, real-time signal detection, and USB 3.0 data transfer for electrophysiology applications.
MEA2100-System Family
A family of in vitro microelectrode array systems with flexible electrode counts and layouts for cardiac, neuronal, and stem cell applications, supporting recording and stimulation.
Multiwell-MEA-System
A high-throughput in vitro electrophysiology system using standard 24- and 96-well plates with up to 1152 electrodes for drug screening and safety pharmacology.
CMOS-MEA5000-System
A CMOS-based microelectrode array system with over 4000 recording sites for high-resolution electrical activity recordings at sub-cellular level.

Show all 6 products

+ 3 more: MEA2100-System Family, Multiwell-MEA-System, CMOS-MEA5000-System

Similar companies

Show all 6 companies

About Multi Channel Systems MCS GmbH

Products: Mesh MEA, IntraCell & MEA2100 Mini, IFB-C Multiboot Interface Board, MEA2100-System Family, Multiwell-MEA-System, CMOS-MEA5000-System
Focus areas: Electrophysiology, microelectrode arrays, scientific instruments, neuroscience research, cardiac research, in vitro research, high-throughput screening, lab automation
Headquarters: Reutlingen, Baden-Württemberg, Germany
Founded: 1996
Employees: 51–100